399 related articles for article (PubMed ID: 32092381)
1. Therapeutic genome editing in cardiovascular diseases.
Nishiga M; Qi LS; Wu JC
Adv Drug Deliv Rev; 2021 Jan; 168():147-157. PubMed ID: 32092381
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
3. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
Musunuru K
J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
[TBL] [Abstract][Full Text] [Related]
4. Genome Editing for the Study of Cardiovascular Diseases.
Chadwick AC; Musunuru K
Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing for Cardiovascular Diseases-A Brief Review for Cardiologists.
Hagiwara N
Am J Cardiol; 2019 Mar; 123(6):1002-1006. PubMed ID: 30606452
[TBL] [Abstract][Full Text] [Related]
6. Genome editing in cardiovascular diseases.
Strong A; Musunuru K
Nat Rev Cardiol; 2017 Jan; 14(1):11-20. PubMed ID: 27609628
[TBL] [Abstract][Full Text] [Related]
7. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
[TBL] [Abstract][Full Text] [Related]
8. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
9. Implications of CRISPR-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases.
Sheikh Beig Goharrizi MA; Ghodsi S; Memarjafari MR
Curr Probl Cardiol; 2023 May; 48(5):101603. PubMed ID: 36682390
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
13. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
14. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
Li Y; Song YH; Liu B; Yu XY
Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
[TBL] [Abstract][Full Text] [Related]
15. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
Motta BM; Pramstaller PP; Hicks AA; Rossini A
Stem Cells Int; 2017; 2017():8960236. PubMed ID: 29434642
[TBL] [Abstract][Full Text] [Related]
16. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
Alagoz M; Kherad N
Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
[TBL] [Abstract][Full Text] [Related]
17. CRISPR and cardiovascular diseases.
Musunuru K
Cardiovasc Res; 2023 Mar; 119(1):79-93. PubMed ID: 35388882
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
19. CRISPR editing in biological and biomedical investigation.
Huang J; Wang Y; Zhao J
J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
[TBL] [Abstract][Full Text] [Related]
20. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]